{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T22:09:35Z","timestamp":1766268575277},"reference-count":46,"publisher":"Impact Journals, LLC","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2019,8,1]]},"DOI":"10.18632\/aging.102125","type":"journal-article","created":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T22:52:01Z","timestamp":1564699921000},"page":"5433-5444","source":"Crossref","is-referenced-by-count":5,"title":["Genome-wide association study identifies <i>CBFA2T3<\/i> affecting the rate of CSF A\u03b242 decline in non-demented elders"],"prefix":"10.18632","volume":"11","author":[{"given":"Kai-Xin","family":"Dou","sequence":"first","affiliation":[{"name":"Department of Neurology, Qingdao Municipal Hospital Affiliated to Qingdao University, Qingdao, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can","family":"Zhang","sequence":"additional","affiliation":[{"name":"Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Diseases (MIND), Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Chen","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Qingdao Municipal Hospital Affiliated to Qingdao University, Qingdao, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Qingdao Municipal Hospital Affiliated to Qingdao University, Qingdao, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie-Qiong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Qingdao Municipal Hospital Affiliated to Qingdao University, Qingdao, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-Peng","family":"Cao","sequence":"additional","affiliation":[{"name":"Clinical Research Center, Qingdao Municipal Hospital, Qingdao University, Qingdao, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Qingdao Municipal Hospital Affiliated to Qingdao University, Qingdao, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Tai","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Neurology and Institute of Neurology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2019,8,1]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers.","volume":"1","author":"Trojanowski","year":"2013","journal-title":"Lancet Neurol"},{"key":"2","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1001\/jama.2015.4668","article-title":"Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.","volume":"31","author":"Arnold","year":"2015","journal-title":"JAMA"},{"key":"3","doi-asserted-by":"publisher","first-page":"e1682","DOI":"10.1212\/WNL.0000000000005476","article-title":"Prevalence of preclinical Alzheimer disease: comparison of current classification systems.","volume":"9","author":"Skoog","year":"2018","journal-title":"Neurology"},{"key":"4","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S1474-4422(14)70194-2","article-title":"Age-specific population frequencies of cerebral \u03b2-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study.","volume":"1","author":"Petersen","year":"2014","journal-title":"Lancet Neurol"},{"key":"5","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: toward a biological definition of Alzheimer\u2019s disease.","volume":"1","author":"Montine","year":"2018","journal-title":"Alzheimers Dement"},{"key":"6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers.","volume":"8","author":"Dubois","year":"2016","journal-title":"Neurology"},{"key":"7","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.dadm.2018.04.001","article-title":"Staging of amyloid \u03b2, t-tau, regional atrophy rates, and cognitive change in a nondemented cohort: results of serial mediation analyses.","volume":"1","author":"DeCarli","year":"2018","journal-title":"Alzheimers Dement (Amst)"},{"key":"8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease.","volume":"7","author":"Rowe","year":"2011","journal-title":"Alzheimers Dement"},{"key":"9","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria.","volume":"1","author":"Engelborghs","year":"2014","journal-title":"Lancet Neurol"},{"key":"10","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1001\/jamaneurol.2014.4530","article-title":"Predicting Reduction of Cerebrospinal Fluid \u03b2-Amyloid 42 in Cognitively Healthy Controls.","volume":"7","author":"Weiner","year":"2015","journal-title":"JAMA Neurol"},{"key":"11","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1097\/NEN.0000000000000114","article-title":"Theoretical impact of Florbetapir (18F) amyloid imaging on diagnosis of alzheimer dementia and detection of preclinical cortical amyloid.","volume":"7","author":"Kukull","year":"2014","journal-title":"J Neuropathol Exp Neurol"},{"key":"12","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/brain\/awu367","article-title":"Independent information from cerebrospinal fluid amyloid-\u03b2 and florbetapir imaging in Alzheimer\u2019s disease.","volume":"13","author":"Weiner","year":"2015","journal-title":"Brain"},{"key":"13","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1093\/brain\/aww015","article-title":"Cerebrospinal fluid analysis detects cerebral amyloid-\u03b2 accumulation earlier than positron emission tomography.","volume":"13","author":"Hansson","year":"2016","journal-title":"Brain"},{"key":"14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/archneurol.2011.221","article-title":"Autosomal recessive causes likely in early-onset Alzheimer disease.","volume":"6","author":"Cutler","year":"2012","journal-title":"Arch Neurol"},{"key":"15","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.tig.2012.03.004","article-title":"Pathway analysis of genomic data: concepts, methods, and prospects for future development.","volume":"2","author":"Saykin","year":"2012","journal-title":"Trends Genet"},{"key":"16","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/ane.12571","article-title":"Donepezil 23 mg in Asian patients with moderate-to-severe Alzheimer\u2019s disease.","volume":"13","author":"Kubota","year":"2017","journal-title":"Acta Neurol Scand"},{"key":"17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1212\/WNL.0b013e318204a397","article-title":"Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort.","volume":"7","author":"Aisen","year":"2011","journal-title":"Neurology"},{"key":"18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1001\/jamaneurol.2017.3029","article-title":"Amyloid \u03b2 Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia.","volume":"7","author":"Snitz","year":"2018","journal-title":"JAMA Neurol"},{"key":"19","doi-asserted-by":"publisher","first-page":"e1306","DOI":"10.1212\/WNL.0000000000005291","article-title":"Age-accelerated cognitive decline in asymptomatic adults with CSF \u03b2-amyloid.","volume":"9","author":"Carlsson","year":"2018","journal-title":"Neurology"},{"key":"20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1001\/jamapsychiatry.2017.3391","article-title":"Association of Cerebral Amyloid-\u03b2 Aggregation With Cognitive Functioning in Persons Without Dementia.","volume":"7","author":"Wallin","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"21","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1093\/brain\/awy150","article-title":"Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults.","volume":"14","author":"Resnick","year":"2018","journal-title":"Brain"},{"key":"22","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1093\/brain\/awv007","article-title":"Amyloid-\u03b2 deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression.","volume":"13","author":"Sperling","year":"2015","journal-title":"Brain"},{"key":"23","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1001\/jamaneurol.2014.446","article-title":"Emerging \u03b2-amyloid pathology and accelerated cortical atrophy.","volume":"7","author":"Weiner","year":"2014","journal-title":"JAMA Neurol"},{"key":"24","doi-asserted-by":"publisher","first-page":"18425","DOI":"10.1523\/JNEUROSCI.2775-13.2013","article-title":"Frontotemporal network connectivity during memory encoding is increased with aging and disrupted by beta-amyloid.","volume":"3","author":"Jagust","year":"2013","journal-title":"J Neurosci"},{"key":"25","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1002\/dvdy.22021","article-title":"Regional expression of MTG genes in the developing mouse central nervous system.","volume":"23","author":"Nakagawa","year":"2009","journal-title":"Dev Dyn"},{"key":"26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ydbio.2004.10.010","article-title":"The expression and function of MTG\/ETO family proteins during neurogenesis.","volume":"27","author":"Kintner","year":"2005","journal-title":"Dev Biol"},{"key":"27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.neulet.2010.03.004","article-title":"Interaction of MTG family proteins with NEUROG2 and ASCL1 in the developing nervous system.","volume":"47","author":"Koyano-Nakagawa","year":"2010","journal-title":"Neurosci Lett"},{"key":"28","doi-asserted-by":"publisher","first-page":"31253","DOI":"10.1074\/jbc.M114.581918","article-title":"Neurogenin 2 mediates amyloid-\u03b2 precursor protein-stimulated neurogenesis.","volume":"28","author":"Small","year":"2014","journal-title":"J Biol Chem"},{"key":"29","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1126\/science.2949367","article-title":"Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus.","volume":"23","author":"Neve","year":"1987","journal-title":"Science"},{"key":"30","doi-asserted-by":"publisher","first-page":"e6779","DOI":"10.1371\/journal.pone.0006779","article-title":"New Alzheimer amyloid beta responsive genes identified in human neuroblastoma cells by hierarchical clustering.","volume":"4","author":"Hartmann","year":"2009","journal-title":"PLoS One"},{"key":"31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.gene.2016.04.032","article-title":"Transfer of three transcription factors via a lentiviral vector ameliorates spatial learning and memory impairment in a mouse model of Alzheimer\u2019s disease.","volume":"58","author":"Zhao","year":"2016","journal-title":"Gene"},{"key":"32","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/74833","article-title":"Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer\u2019s disease.","volume":"3","author":"Yankner","year":"2000","journal-title":"Nat Neurosci"},{"key":"33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/0896-6273(93)90315-I","article-title":"Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein.","volume":"1","author":"Rydel","year":"1993","journal-title":"Neuron"},{"key":"34","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00401-015-1386-3","article-title":"Amyloid \u03b2 oligomers in Alzheimer\u2019s disease pathogenesis, treatment, and diagnosis.","volume":"12","author":"Klein","year":"2015","journal-title":"Acta Neuropathol"},{"key":"35","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/alzrt226","article-title":"Amyloid \u03b2-protein oligomers and Alzheimer\u2019s disease.","volume":"5","author":"Teplow","year":"2013","journal-title":"Alzheimers Res Ther"},{"key":"36","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1083\/jcb.201206146","article-title":"Rbfox3-regulated alternative splicing of Numb promotes neuronal differentiation during development.","volume":"20","author":"Kawamoto","year":"2013","journal-title":"J Cell Biol"},{"key":"37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.neulet.2013.10.037","article-title":"Altered subcellular localization of the NeuN\/Rbfox3 RNA splicing factor in HIV-associated neurocognitive disorders (HAND).","volume":"55","author":"Brown","year":"2014","journal-title":"Neurosci Lett"},{"key":"38","doi-asserted-by":"publisher","first-page":"e0164164","DOI":"10.1371\/journal.pone.0164164","article-title":"Neuronal Splicing Regulator RBFOX3 (NeuN) Regulates Adult Hippocampal Neurogenesis and Synaptogenesis.","volume":"1","author":"Huang","year":"2016","journal-title":"PLoS One"},{"key":"39","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1001\/jama.2017.6669","article-title":"Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons.","volume":"31","author":"Aisen","year":"2017","journal-title":"JAMA"},{"key":"40","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/S1474-4422(16)30125-9","article-title":"Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer\u2019s disease pathophysiology (SNAP) or Alzheimer\u2019s disease pathology: a longitudinal study.","volume":"1","author":"Villemagne","year":"2016","journal-title":"Lancet Neurol"},{"key":"41","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1001\/jamaneurol.2018.0629","article-title":"Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting.","volume":"7","author":"Jack","year":"2018","journal-title":"JAMA Neurol"},{"key":"42","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.tips.2015.03.002","article-title":"Amyloid biomarkers in Alzheimer\u2019s disease.","volume":"3","author":"Zetterberg","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"43","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1001\/jamaneurol.2018.0629","article-title":"The National Institute on Aging-Alzheimer\u2019s Association Framework on Alzheimer\u2019s disease: application to clinical trials.","volume":"1","author":"Cummings","year":"2019","journal-title":"Alzheimers Dement"},{"key":"44","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1212\/WNL.0000000000001991","article-title":"Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease.","volume":"8","author":"Hansson","year":"2015","journal-title":"Neurology"},{"key":"45","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jalz.2010.08.230","article-title":"Transforming cerebrospinal fluid A\u03b242 measures into calculated Pittsburgh Compound B units of brain A\u03b2 amyloid.","volume":"7","author":"Jack","year":"2011","journal-title":"Alzheimers Dement"},{"key":"46","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/gepi.20303","article-title":"Estimation of the multiple testing burden for genomewide association studies of nearly all common variants.","volume":"3","author":"Daly","year":"2008","journal-title":"Genet Epidemiol"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T19:11:00Z","timestamp":1599073860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,1]]},"references-count":46,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2019,8,15]]}},"alternative-id":["102125","31370031"],"URL":"https:\/\/doi.org\/10.18632\/aging.102125","relation":{},"ISSN":["1945-4589"],"issn-type":[{"type":"electronic","value":"1945-4589"}],"subject":[],"published":{"date-parts":[[2019,8,1]]}}}